CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
CITY THERAPEUTICS, INC.
$21.46−0.94 (-4.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
1 of City Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 19, 2026 | SEC EDGAR |